A prescription eye drug originally used to treat glaucoma is also safe and effective for adults who want the longer, thicker eyelashes, a U.S. advisory panel said on Friday. The drug, by Botox maker Allergan Inc (AGN.N: Quote, Profile, Research, Stock Buzz), was first studied to help relieve eye pressure when patients began reporting an unusual side effect: eyelash growth. The company is now seeking U.S. approval to market the new use under the brand name Latisse.
At a Food and Drug Administration panel meeting, outside advisers overwhelmingly said years of data gathered from the glaucoma use under the name Lumigan showed the drops helped boost lashes. "I have absolutely no reason to question the efficacy," said panelist M. Roy Wilson, an ophthalmologist from the University of Colorado. Wilson and others also cited the lack of serious side effects with the drug in clinical trials.